XML 55 R25.htm IDEA: XBRL DOCUMENT
v3.25.2

Loss Per Share | 12 Months Ended
--- | ---
May 31, 2025
Earnings Per Share [Abstract] |
Loss Per Share | Loss Per Share The following is a reconciliation of the denominator of the basic and diluted net loss per share computations for the periods presented:
| Fiscal Year Ended
| May 31, 2025 |  | May 31, 2024 |  | May 31, 2023
Net loss | $ | (231,065) |  |  | $ | (149,671) |  |  | $ | (45,606) |
Net loss attributable to noncontrolling interest | — |  |  | (397) |  |  | (960) |
Preferred dividends | (2,615) |  |  | — |  |  | — |
Net loss attributable to common stockholders | $ | (233,680) |  |  | $ | (149,274) |  |  | $ | (44,646) |
Net loss attributable to common stockholders |  |  |  |  |
Continuing operations | $ | (160,950) |  |  | $ | (73,979) |  |  | $ | (43,528) |
Discontinued operations | (72,730) |  |  | (75,295) |  |  | (1,118) |
Net loss | $ | (233,680) |  |  | $ | (149,274) |  |  | $ | (44,646) |
Basic and diluted net loss per share attributable to common stockholders |  |  |  |  |
Continuing operations | $ | (0.80) |  |  | $ | (0.65) |  |  | $ | (0.46) |
Discontinued operations | (0.36) |  |  | (0.66) |  |  | (0.01) |
Basic and diluted net loss per share | $ | (1.16) |  |  | $ | (1.31) |  |  | $ | (0.47) |
Basic and diluted weighted average number of shares outstanding | 201,194,451 |  |  | 114,061,414 |  |  | 93,976,233 |
As of May 31, 2025 and 2024, the Company had approximately 14.1 million and 12.1 million shares, respectively, of granted but unvested restricted stock, performance stock, and restricted stock units that would have a potentially dilutive effect on earnings per share. As of May 31, 2025, the Company had approximately 21.7 million shares associated with the Company’s preferred stock which have been excluded from the calculation of earnings per share because the effect of those shares would be antidilutive while as of May 31, 2024, the Company had approximately 19.0 million shares associated with the Yorkville Convertible Debt which have been excluded from the calculation of earnings per share because the effect of those shares would be antidilutive. Additionally, the Company had approximately 17.1 million and 12.3 million warrants outstanding as of May 31, 2025 and May 31, 2024, respectively, which have been excluded from the calculations of earnings per share because the effect of those shares would be antidilutive. Lastly, if the Company's Convertible Notes were converted into shares of the Company's common stock as of May 31, 2025, approximately 46.1 million shares were excluded from the calculations of earnings per share because the effect of those shares would be antidilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration